Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOAP Regimen for Relapsed/Refractory Classical Hodgkin's Lymphoma After DP Failure
NCT04026269Phase 2Unknown
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mechlorethamine, vindesine, doxorubicin, prednisone in Classical Hodgkin Lymphoma (cHL). Status: unknown.
02
Drugs
mechlorethaminevindesinedoxorubicinprednisone
03
Conditions
Classical Hodgkin Lymphoma (cHL)
Beyond the preview
Go deeper on NCT04026269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04026269.